Streptozotocin (STZ) diabetes enhances benzo(α)pyrene induced renal injury in Sprague Dawley rats

Toxicology Letters

Volumn 164, Issue 3, 2006, Pages 214-220

  Valentovic, Monica A ^a   Alejandro, Napoleon ^b   Betts Carpenter, A ^a   Brown, Patrick I ^a   Ramos, Kenneth ^c  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Benzo( )pyrene; Diabetic nephropathy; Microalbuminuria; Nephrotoxicity

Indexed keywords

ALBUMIN; BENZO[A]PYRENE; CREATININE; GLUCOSE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MASS; MICROSCOPY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DISEASE PREDISPOSITION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; PATHOLOGY; POLLUTANT; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; BENZO(A)PYRENE; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL POLLUTANTS; FEMALE; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745938185     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2005.12.009     Document Type: Article

References (39)

1. Alejandro N.F., Parrish A.R., Bowes R.C., Burghardt R.C., and Ramos K.S. Phenotypic profiles of cultured glomerular cells following repeated cycles of hydrocarbon injury. Kidney Intl. 57 (2000) 1571-1580
2. Bertazzi P.A., Pesatori A.C., Zocchetti C., and Latocca R. Mortality study of cancer risk among oil refinery workers. Int. Arch. Occup. Environ. Health 61 4 (1989) 261-270
3. Boffetta P., Jourenkova N., and Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8 3 (1997) 444-472
4. Borghoff S.J., Short B.G., and Swenberg J.A. Biochemical mechanisms and pathobiology of alpha 2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 349-357
5. Bowes III R.C., Parrish A.R., Steinberg M.A., Willer K.L., Zhao W., Savas U., Jeffcoat C.R., Safe S.H., and Ramos K.S. Atypical cytochrome P450 induction profiles in glomerular mesangial cells at the mRNA and enzyme level: evidence for CYP1A1 and CYP1B1 expression and their involvement in benzo(α)pyrene metabolism. Biochem. Pharmacol. 52 4 (1996) 587-595
6. Chuahirun T., Simoni J., Hudson C., Seipel T., Khanna A., Harrist R.B., and Wesson D.E. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am. J. Med. Sci. 327 2 (2004) 57-67
7. Conney A.H. Induction of microsomal enzymes by foreing chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42 (1982) 4875-4917
8. Couchman J.R., Beavan L.A., and McCarthy K.J. Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int. 45 2 (1994) 328-335
9. Dalla Vestra M., Masiero A., Roiter A.M., Saller A., Crepaldi G., and Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52 4 (2003) 1031-1035
10. Eliasson B. Cigarette smoking and diabetes. Prog. Cardiovasc. Dis. 45 5 (2003) 405-413
11. Falahatpisheh M.H., Donnelly K.C., and Ramos K.S. Antagonistic interactions among nephrotoxic polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health (Part A) 62 (2001) 543-560
12. Falahatpisheh M.H., and Ramos K.S. Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene 22 14 (2003) 2160-2171
13. Furihata C., and Matsushima T. Mutagens and carcinogens in foods. Ann. Rev. Nutr. 6 (1986) 67-94
14. Hollenberg N.K. Treatment of the patient with diabetes mellitus and risk of nephropathy: what do we know, and what do we need to learn?. Arch. Intern. Med. 164 2 (2004) 125-130
15. Hotz P. Occupational hydrocarbon exposure and chronic nephropathy. Toxicology 90 3 (1994) 163-283
16. Jawa A., Kcomt J., and Fonseca V.A. Diabetic nephropathy and retinopathy. Med. Clin. North Am. 88 4 (2004) 1001-1036
17. Knuckles M.E., Inyand F., and Ramesh A. Acute and subchronic oral toxicities of benzo(α)pyrene in f-344 rats. Toxicol. Sci. 61 (2001) 382-388
18. Lehman-McKeeman L.D., Rodriguez P.A., Takigiku R., Caudill D., and Fey M.L. d-Limonene-induced male rat-specific nephrotoxicity: evaluation of the association between d-limonene and alpha 2u-globulin. Toxicol. Appl. Pharmacol. 99 2 (1989) 250-259
19. Lock E.A., Stonard M.D., and Elcombe C.R. The induction of omega and beta-oxidation of fatty acids and effect on alpha 2u globulin content in the liver and kidney of rats administered 2,2,4-trimethylpentane. Xenobiotica 17 4 (1987) 513-522
20. Marshall S.M. Recent advances in diabetic nephropathy. Clin. Med. 4 3 (2004) 277-282
21. Marshall T. Detection of protein in polyacrylamide gels using an improved silver stain. Anal. Biochem. 136 (1984) 340-346
22. Marshall T., and Williams K.M. Simplified sodium dodceyl sulfate-polyacrylamide gel electrophoresis of unconcentrated urine with enhanced resolution and detection sensitivity. Clin. Chem. 33 10 (1987) 1889-1897
23. Mauer S.M., Steffes M.W., Goetz F.C., Sutherland D.E., and Brown D.M. Diabetic nephropathy. A perspective. Diabetes 32 Suppl. 2 (1983) 52-55
24. Mogensen C.E. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J. Intern. Med. 254 1 (2003) 45-66
25. Mumford J.L., Li X., Hu F., Lu X.B., and Chuang J.C. Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 16 12 (1995) 3031-3036
26. Nakamura T., Kawagoe Y., and Koide H. Effect of cigarette smoking on urinary podocyte excretion in early diabetic nephropathy. Diabetes Care 26 4 (2003) 1324-1325
27. Nanez A., Alejandro N.F., Falahatpisheh M.H., Kerzee J.K., Roths J.B., and Ramos K.S. Disruption of glomerular cell-cell and cell-matrix interactions in hydrocarbon nephropathy. Am. J. Physiol. Renal. Physiol. 289 6 (2005) F1291-F1303
28. Offenberg J.H., Eisenreich S.J., Chen L.C., Cohen M.D., Chee G., Prophete C., Weisel C., and Lioy P.J. Persistent organic pollutants in the dusts that settled across lower Manhattan after September 11, 2001. Environ. Sci. Technol. 37 3 (2003) 502-508
29. Orth S.R. Smoking and the kidney. J. Am. Soc. Nephrol. 13 (2002) 1663-1672
30. Parrish A.R., Alejandro N.F., bral C.M., Kerzee J.K., Bowes R.C., and Ramos K.S. Characterization of glomerular cell phenotypes following repeated cycles of benzo(α)pyrene injury in vitro. Biochem. Pharmacol. 64 (2002) 31-39
31. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34 2 (1982) 189-222
32. Pukkala E. Cancer incidence among Finnish oil refinery workers, 1971-1994. J. Occup. Environ. Med. 40 8 (1998) 675-679
33. Rushton L. A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia. Environ. Health Perspect. 101 Suppl. 6 (1993) 77-84
34. Sawicki P.T., Didjurgeit U., Muhlhauser I., Bender R., Heinemann L., and Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17 2 (1994) 126-231
35. Scott L.A., Madan E., and Valentovic M.A. Attenuation of cisplatin nephrotoxicity by streptozotocin (STZ) induced diabetes. Fundam. Appl. Toxicol. 12 3 (1989) 530-539
36. Stohs S.J., Reinke L.A., Hassing J.M., and Rosenberg H. Benzo[a]pyrene metabolism by hepatic and extrahepatic tissues in streptozotocin-diabetic rats. Drug Metab. Dispos. 7 1 (1979) 49-51
37. Valentovic M.A., and Ball J.G. Cephaloridine nephrotoxicity in diabetic rats: modulation by insulin treatment. Toxicology 100 (1995) 11-16
38. Valentovic M.A., Ball J.G., and Rogers B.A. Comparison of cephaloridine renal accumulation and urinary excretion between normoglycemic and diabetic animals. Toxicology 108 (1996) 93-99
39. Wu M.T., Simpson C.D., Christiani D.C., and Hecht S.S. Relationship of exposure to coke-oven emissions and urinary metabolites of benzo(a)pyrene and pyrene in coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 11 3 (2002) 311-314